FSM Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Sell
826
-34
-4% -$16.3K 0.04% 212
2026
Q1
$423K Buy
860
+48
+6% +$26.1K 0.05% 185
2025
Q4
$471K Buy
812
+81
+11% +$45.8K 0.06% 174
2025
Q3
$354K Buy
731
+230
+46% +$107K 0.05% 217
2025
Q2
$210K Buy
501
+90
+22% +$37.6K 0.03% 270
2025
Q1
$205K Buy
+411
New +$223K 0.05% 206
2024
Q4
Sell
-339
Closed -$210K 206
2024
Q3
$210K Buy
+339
New +$201K 0.06% 179
2023
Q2
Sell
-422
Closed -$243K 175
2023
Q1
$243K Buy
+422
New +$238K 0.14% 133

Other funds holding TMO

FSM Wealth Advisors's TMO Position: Q2 2026 in Review

FSM Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 4% in Q2 2026, selling an estimated $16.3K and leaving 826 shares worth $414K. The position accounts for 0.04% of the portfolio, ranked #212.

FSM Wealth Advisors first reported a position in TMO in Q1 2023 and has held it in 8 quarters since. The position peaked at $471K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • FSM Wealth Advisors held 826 shares of Thermo Fisher Scientific worth $414K as of Q2 2026.
  • FSM Wealth Advisors sold 34 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.3K.
  • Thermo Fisher Scientific made up 0.04% of FSM Wealth Advisors's portfolio in Q2 2026, its #212 holding.
  • FSM Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 8 quarters since.
  • FSM Wealth Advisors's Thermo Fisher Scientific position peaked at $471K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.